CARL Carlsmed, Inc.
$14.91▲ +2.62%
Healthcare
Other
Pre-market
$15.50▲ +3.96%
Oct 27, 7:20 AM ET
Volume 109.3K
Avg Volume (10D) 67.6K
Key Metrics & Fundamentals
Market Cap
$407.08M
P/E Ratio
–
Div Yield
0.00%
52W Range
8.50 - 17.23
% vs 50 MA
-0.68%
% vs 200 MA
20.56%
RSI-14
55.1
MACD Histogram
+0.0900
Beta (1Y vs SPY)
1.10
Free Cash Flow
-$8.11M
Gross Rev
$18.94M
Gross Profit
$14.54M
EBITDA
-$10.07M
COGS
$4.40M
Operating Exp
$25.58M
Operating Income
-$11.04M
EBIT
-$11.04M
Pretax Income
-$10.51M
Net Income
-$10.51M
EPS (Diluted)
-0.39
Price & Volume History
Loading chart…
Recent News
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
GlobeNewswire · Oct 14, 2026 9:00 AM ET
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 2, 2026 4:01 PM ET
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
GlobeNewswire · Oct 1, 2026 9:00 AM ET
Carlsmed names new CFO
MedTech Dive · Sep 29, 2026 10:00 AM ET
Carlsmed Names Richard Heppenstall CFO; Company Reiterates Fiscal 2026 Revenue Guidance
MT Newswires · Sep 28, 2026 9:24 AM ET
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
GlobeNewswire · Sep 28, 2026 8:30 AM ET
Carlsmed Sues DeGen Medical, Alleging Infringement of Eight Patents
MT Newswires · Sep 16, 2026 4:15 AM ET
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical
GlobeNewswire · Sep 15, 2026 7:00 PM ET
Carlsmed Names Jeff Bertolini COO
MT Newswires · Sep 8, 2026 4:16 PM ET
Carlsmed, Inc. Announces Chief Operating Officer Appointment
GlobeNewswire · Sep 8, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CARL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.